Heterogeneous Cell Types in Single-cell-derived Clones of MCF7 and MDA-MB-231 Cells.

BACKGROUND/AIM Variations in cell phenotype in a single-cell-derived clone may result from asymmetric cell divisions that lead to different cell fate in a homogenous microenvironment. The aim of this study was to demonstrate the extent of cell variety in single-cell-derived clones and propose a different strategy in treating cancer by observed phenotypic heterogeneity in cellular types. Additionally, the role of metabolic enzyme and housekeeping gene, glyceraldehyde-3-phosphate dehydrogenase (GAPDH), in cellular phenotype was evaluated in two breast cancer cell lines. MATERIALS AND METHODS Two GAPDH-overexpressing breast cancer cell lines, MCF7-GAPDH-RFP (MCF7-RFP) and MDA-MB-231-GAPDH-RFP (MDA-RFP), were established. Microscopic recordings were made at 12-h intervals in single-cell-derived clones of both cell lines up to 8-10 days. Crystal violet and Hoechst 33342 (Hoechst), as well as specific cell-type (epithelial and mesenchymal) antibodies, were used for cytochemical and immunohistochemical staining analyses, respectively, at 3, 6 and 9 days during cell growth. RESULTS Three types of clones with distinct morphologies were identified as holo-, mero- and paraclones. The rates of colony survival during cell growth were 8.3 and 41.7% in MCF7-RFP and MDA-RFP, respectively. Although no significant difference was found in the colony forming efficiency (CFE) of both MCF7 and MDA-MD-231 wild-type cells, a markedly significant difference was seen in the CFE of MCF7-RFP and MDA-RFP cells (p=0.001). Wild-type cell-derived holoclones of both cell lines showed drug resistance to doxorubicin (Dox). However, levels of proliferating cell nuclear antigen (PCNA) and vimentin (VIM) marginally decreased in Dox-treated clones. Furthermore, high level of intraclonal heterogeneity was found for CD44, CD140a, VIM, fibronectin (FN), focal adhesion kinase (FAK), paxillin (PXN) and vinculin (VCL) in MCF7 and MDA clones during different stages of clonal development. Expressions of CD140a, FN, VIM and FAK were induced in GAPDH-red fluorescent protein (RFP)-tagged clones of both cell lines. CONCLUSION The GAPDH-RFP recombinant protein played an important role in morphological heterogeneity detection in early stages of clonal development. Moreover, phenotypic heterogeneity in clones, caused by the cells expressing specific antigens, such as CD44, CD140a, FN, VIM, FAK and VCL, can be the right target for therapeutic drugs.

[1]  D. Schlaepfer,et al.  FAK in cancer: mechanistic findings and clinical applications , 2014, Nature Reviews Cancer.

[2]  D. Schlaepfer,et al.  Focal adhesion kinase: switching between GAPs and GEFs in the regulation of cell motility. , 2009, Current opinion in cell biology.

[3]  Darren R. Williams,et al.  Chemical targeting of GAPDH moonlighting function in cancer cells reveals its role in tubulin regulation. , 2014, Chemistry & biology.

[4]  Yao‐Hua Song,et al.  Epithelial–mesenchymal transition in breast cancer lines is mediated through PDGF‐D released by tissue‐resident stem cells , 2012, International journal of cancer.

[5]  H. Ditzel,et al.  Functional Heterogeneity within the CD44 High Human Breast Cancer Stem Cell-Like Compartment Reveals a Gene Signature Predictive of Distant Metastasis , 2012, Molecular medicine.

[6]  R. Henkelman,et al.  Identification of human brain tumour initiating cells , 2004, Nature.

[7]  K. Polyak,et al.  The microenvironment in breast cancer progression: biology and implications for treatment , 2011, Breast Cancer Research.

[8]  Jun-Ping Liu,et al.  GAPDH: A common enzyme with uncommon functions , 2012, Clinical and experimental pharmacology & physiology.

[9]  J. Masters,et al.  Clonogenicity: Holoclones and Meroclones Contain Stem Cells , 2014, PloS one.

[10]  F. Mannello.  Understanding breast cancer stem cell heterogeneity: time to move on to a new research paradigm , 2013, BMC Medicine.

[11]  Suwei Wang,et al.  Activation of nuclear factor-kappaB during doxorubicin-induced apoptosis in endothelial cells and myocytes is pro-apoptotic: the role of hydrogen peroxide. , 2002, The Biochemical journal.

[12]  D. Green,et al.  Novel roles for GAPDH in cell death and carcinogenesis , 2009, Cell Death and Differentiation.

[13]  T. Hunter,et al.  Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase , 1994, Nature.

[14]  A. Rajasekaran,et al.  Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis. , 2006, Cancer research.

[15]  M. Iacocca,et al.  Immunohistochemical analyses of focal adhesion kinase expression in benign and malignant human breast and colon tissues: correlation with preinvasive and invasive phenotypes. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[16]  J. Guan,et al.  Focal adhesion kinase and its signaling pathways in cell migration and angiogenesis. , 2011, Advanced drug delivery reviews.

[17]  M. Przybyszewska,et al.  Mouse sarcoma L1 cell line holoclones have a stemness signature , 2010, Cell proliferation.

[18]  Kornelia Polyak,et al.  Heterogeneity in breast cancer. , 2011, The Journal of clinical investigation.

[19]  K. Hahn,et al.  Vinculin modulation of paxillin–FAK interactions regulates ERK to control survival and motility , 2004, The Journal of cell biology.

[20]  P. Barker,et al.  Nuclear factor-kappaB induced by doxorubicin is deficient in phosphorylation and acetylation and represses nuclear factor-kappaB-dependent transcription in cancer cells. , 2005, Cancer research.

[21]  Franziska Michor,et al.  Intratumor Heterogeneity in Evolutionary Models of Tumor Progression , 2011, Genetics.

[22]  Kornelia Polyak,et al.  Cellular heterogeneity and molecular evolution in cancer. , 2013, Annual review of pathology.

[23]  S. Morrison,et al.  Prospective identification of tumorigenic breast cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[24]  A. Giuliano,et al.  Critical protein GAPDH and its regulatory mechanisms in cancer cells , 2015, Cancer biology & medicine.

[25]  K. Fujimoto,et al.  Glyceraldehyde-3-phosphate Dehydrogenase Enhances Transcriptional Activity of Androgen Receptor in Prostate Cancer Cells* , 2007, Journal of Biological Chemistry.

[26]  Shusen Zheng,et al.  G15 sensitizes epithelial breast cancer cells to doxorubicin by preventing epithelial-mesenchymal transition through inhibition of GPR30. , 2015, American journal of translational research.

[27]  Wenjun Guo,et al.  The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells , 2008, Cell.

[28]  Charlotte Kuperwasser,et al.  Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy , 2008, Breast Cancer Research.

[29]  W. Martin,et al.  Cell individuality : the bistability of competence development , 2005 .

[30]  S. Vinogradov,et al.  Cancer stem cells and drug resistance: the potential of nanomedicine. , 2012, Nanomedicine.

[31]  Kornelia Polyak,et al.  Breast Tumor Heterogeneity: Cancer Stem Cells or Clonal Evolution? , 2007, Cell cycle.

[32]  Changsong Xu,et al.  Paxillin functions as an oncogene in human gliomas by promoting cell migration and invasion , 2016, OncoTargets and therapy.

[33]  F. Révillion,et al.  Glyceraldehyde-3-phosphate dehydrogenase gene expression in human breast cancer. , 2000, European journal of cancer.

[34]  Carlos Caldas,et al.  A new genome‐driven integrated classification of breast cancer and its implications , 2013, The EMBO journal.

[35]  M. Melamed,et al.  Effects of selected chemotherapeutic agents on PCNA expression in prostate carcinoma cell lines , 2004, Urological Research.

[36]  Qiulian Wu,et al.  Platelet-derived growth factor receptors differentially inform intertumoral and intratumoral heterogeneity. , 2012, Genes & development.